Skip to playerSkip to main contentSkip to footer
  • 4/21/2021
The fight against COVID-19 seemed to turn a corner with the Pfizer and Moderna vaccines emerged. But researchers are now finding that one vulnerable group of people could remain at risk.

Recommended